title: Acute and delayed protective effects of pharmacologically induced hypothermia in an intracerebral hemorrhage stroke model of mice.
abstract: Hemorrhagic stroke, including intracerebral hemorrhage (ICH), is a devastating subtype of stroke; yet, effective clinical treatment is very limited. Accumulating evidence has shown that mild to moderate hypothermia is a promising intervention for ischemic stroke and ICH. Current physical cooling methods, however, are less efficient and often impractical for acute ICH patients. The present investigation tested pharmacologically induced hypothermia (PIH) using the second-generation neurotensin receptor (NTR) agonist HPI-201 (formerly known as ABS-201) in an adult mouse model with ICH. Acute or delayed administrations of HPI-201 (2mg/kg bolus injection followed by 2 injections of 1mg/kg, i.p.) were initiated at 1 or 24h after ICH. HPI-201 induced mild hypothermia within 30 min and body and brain temperatures were maintained at 32.7 ± 0.4°C for at least 6h without causing observable shivering. With the 1-h delayed treatment, HPI-201-induced PIH significantly reduced ICH-induced cell death and brain edema compared to saline-treated ICH animals. When HPI-201-induced hypothermia was initiated 24h after the onset of ICH, it still significantly attenuated brain edema, cell death and blood-brain barrier breakdown. HPI-201 significantly decreased the expression of matrix metallopeptidase-9 (MMP-9), reduced caspase-3 activation, and increased Bcl-2 expression in the ICH brain. Moreover, ICH mice received 1-h delayed HPI-201 treatment performed significantly better in the neurological behavior test 48 h after ICH. All together, these data suggest that systemic injection of HPI-201 is an effective hypothermic strategy that protects the brain from ICH injury with a wide therapeutic window. The protective effect of this PIH therapy is partially mediated through the alleviation of apoptosis and neurovascular damage. We suggest that pharmacological hypothermia using the newly developed neurotensin analogs is a promising therapeutic treatment for ICH.
authors.affiliation: Department of Anesthesiology, Emory University School of Medicine, Atlanta, GA 30322, United States.
authors.forename: S
authors.initials: S
authors.lastname: Wei
authors.forename: J
authors.initials: J
authors.lastname: Sun
authors.forename: J
authors.initials: J
authors.lastname: Li
authors.forename: L
authors.initials: L
authors.lastname: Wang
authors.forename: C L
authors.initials: CL
authors.lastname: Hall
authors.forename: T A
authors.initials: TA
authors.lastname: Dix
authors.forename: O
authors.initials: O
authors.lastname: Mohamad
authors.forename: L
authors.initials: L
authors.lastname: Wei
authors.forename: S P
authors.initials: SP
authors.lastname: Yu
mesh_terms: D000818:Animals; D015153:Blotting, Western; D001929:Brain Edema / Q000209:etiology; D002543:Cerebral Hemorrhage / Q000378:metabolism / Q000473:pathology / Q000628:therapy*; D004195:Disease Models, Animal; D007036:Hypothermia, Induced / Q000379:methods*; D007150:Immunohistochemistry; D020287:In Situ Nick-End Labeling; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D020127:Recovery of Function; D020521:Stroke / Q000378:metabolism / Q000473:pathology / Q000628:therapy*
keywords: ABS-201; BBB; CNS; HPI-201; ICH; INTERACT; Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage; MMP-9; NSS; NT; NTR; PBS; PIH; SDS–PAGE; TBS-T; TUNEL; Tween in Tris-buffered saline; blood–brain barrier; central nervous system; intracerebral hemorrhage; matrix metallopeptidase-9; neurological stroke scale; neurotensin; neurotensin receptor; pharmacological hypothermia; pharmacologically induced hypothermia; phosphate-buffered saline; rTdT; sodium dodecyl sulfate–polyacrylamide gel electrophoresis; tPA; terminal deoxynucleotidyl transferase dUTP nick end labeling; terminal deoxynucleotidyl transferase recombinant enzyme; tissue plasminogen activator
references.citation: Neuropeptides. 2008 Feb;42(1):79-87
references.pmid: 18045686
references.citation: J Cereb Blood Flow Metab. 2002 Jan;22(1):29-38
references.pmid: 11807391
references.citation: Neurosurgery. 2009 Aug;65(2):352-9; discussion 359
references.pmid: 19625915
references.citation: Neurol Res. 2005 Apr;27(3):229-37
references.pmid: 15845206
references.citation: Brain Res. 2008 Sep 16;1230:281-9
references.pmid: 18657523
references.citation: Crit Care Med. 2009 Jul;37(7 Suppl):S243-9
references.pmid: 19535954
references.citation: Cerebrovasc Dis. 2011;31(3):211-22
references.pmid: 21178344
references.citation: Pharmacotherapy. 2010 May;30(5):493-514
references.pmid: 20412000
references.citation: Exp Transl Stroke Med. 2012 Mar 07;4(1):3
references.pmid: 22397464
references.citation: J Cereb Blood Flow Metab. 1992 Sep;12(5):817-22
references.pmid: 1506446
references.citation: J Neurosci. 1999 Jan 1;19(1):503-10
references.pmid: 9870978
references.citation: Stroke. 1998 Oct;29(10):2171-80
references.pmid: 9756600
references.citation: Stroke. 1993 Jul;24(7):987-93
references.pmid: 8322400
references.citation: Neuropharmacology. 2005 Mar;48(3):417-25
references.pmid: 15721174
references.citation: Expert Rev Neurother. 2008 Aug;8(8):1255-68
references.pmid: 18671669
references.citation: Acta Neurochir Suppl. 2011;111:421-4
references.pmid: 21725794
references.citation: J Cereb Blood Flow Metab. 2000 Dec;20(12):1702-8
references.pmid: 11129786
references.citation: Stroke. 2004 Mar;35(3):764-9
references.pmid: 14976330
references.citation: Acta Neurochir Suppl. 2011;111:9-14
references.pmid: 21725724
references.citation: J Neurosurg. 2001 Jan;94(1):90-6
references.pmid: 11147904
references.citation: Eur J Pharmacol. 2000 Feb 25;390(1-2):107-11
references.pmid: 10708713
references.citation: J Cereb Blood Flow Metab. 2012 Apr;32(4):612-27
references.pmid: 22293989
references.citation: J Cereb Blood Flow Metab. 2004 Apr;24(4):432-40
references.pmid: 15087712
references.citation: Stroke. 2007 Nov;38(11):2941-7
references.pmid: 17901391
references.citation: Neurosci Res. 2007 Mar;57(3):424-33
references.pmid: 17212971
references.citation: Stroke. 2010 Jan;41(1):48-53
references.pmid: 19959538
references.citation: J Cereb Blood Flow Metab. 2012 Jun;32(6):1014-23
references.pmid: 22314269
references.citation: Resuscitation. 2002 Apr;53(1):93-9
references.pmid: 11947985
references.citation: J Cereb Blood Flow Metab. 2003 May;23(5):589-98
references.pmid: 12771574
references.citation: Pharmacol Biochem Behav. 2005 Feb;80(2):341-9
references.pmid: 15680187
references.citation: J Cereb Blood Flow Metab. 2010 Jun;30(6):1079-93
references.pmid: 20354545
references.citation: FASEB J. 2012 Jul;26(7):2799-810
references.pmid: 22459147
references.citation: J Neurochem. 1968 Sep;15(9):917-23
references.pmid: 5682509
references.citation: J Med Chem. 2010 Jun 24;53(12):4623-32
references.pmid: 20481538
references.citation: Neuroscience. 2005;130(4):813-31
references.pmid: 15652981
references.citation: Neuropharmacology. 2010 Jan;58(1):195-8
references.pmid: 19596358
references.citation: J Neurotrauma. 2009 Mar;26(3):313-23
references.pmid: 19216634
references.citation: Stroke. 2006 May;37(5):1266-70
references.pmid: 16574928
references.citation: Behav Brain Res. 2008 Jan 25;186(2):222-9
references.pmid: 17904232
references.citation: Stroke. 2002 Nov;33(11):2636-41
references.pmid: 12411654
references.citation: Dev Neurobiol. 2008 Nov;68(13):1474-86
references.pmid: 18777565
references.citation: Life Sci. 1994;54(2):95-100
references.pmid: 8277823
references.citation: J Med Chem. 2009 Apr 9;52(7):1803-13
references.pmid: 19290594
references.citation: Exp Neurol. 2007 Dec;208(2):277-84
references.pmid: 17927984
references.citation: Stroke. 2001 Apr;32(4):1005-11
references.pmid: 11283404
references.citation: Exp Neurol. 2008 Aug;212(2):386-92
references.pmid: 18538766
references.citation: Lancet Neurol. 2006 Jan;5(1):53-63
references.pmid: 16361023
references.citation: Brain. 2009 Jan;132(Pt 1):26-36
references.pmid: 18772219
references.citation: Can J Neurol Sci. 2008 Nov;35(5):567-72
references.pmid: 19235439
references.citation: Neurocrit Care. 2013 Apr;18(2):178-83
references.pmid: 22864858
references.citation: Neurosci Biobehav Rev. 1997 Jan;21(1):31-44
references.pmid: 8994207
references.citation: Eur J Pharmacol. 1992 Aug 25;219(2):327-9
references.pmid: 1425958
references.citation: J Cereb Blood Flow Metab. 2001 Nov;21(11):1310-9
references.pmid: 11702046
references.citation: J Neurosurg. 2005 Aug;103(2):289-97
references.pmid: 16175859
references.citation: Brain Res. 2008 Mar 10;1198:182-7
references.pmid: 18241848
references.citation: Exp Neurol. 2009 Sep;219(1):156-62
references.pmid: 19445934
references.citation: Stroke. 2000 Jan;31(1):183-92
references.pmid: 10625736
references.citation: Hippocampus. 2008;18(4):386-97
references.pmid: 18172894
references.citation: J Stroke Cerebrovasc Dis. 2008 Jul-Aug;17(4):187-95
references.pmid: 18589338
references.citation: Acta Neurochir Suppl. 1998;71:131-4
references.pmid: 9779165
references.citation: Stroke. 2010 Aug;41(8):1684-9
references.pmid: 20616317
references.citation: Fundam Clin Pharmacol. 1991;5(9):755-67
references.pmid: 1686604
references.citation: Neuropharmacology. 2005 Dec;49(8):1149-59
references.pmid: 16095636
references.citation: Nat Protoc. 2008;3(1):122-8
references.pmid: 18193028
references.citation: J Cereb Blood Flow Metab. 2005 Nov;25(11):1505-16
references.pmid: 15959464
references.citation: Stroke. 1999 Jun;30(6):1167-73
references.pmid: 10356094
references.citation: Stroke. 2012 Dec;43(12):3364-70
references.pmid: 22996953
references.citation: Brain Res. 2004 Aug 13;1017(1-2):85-91
references.pmid: 15261103
references.citation: Neuropharmacology. 1999 Jul;38(7):1027-34
references.pmid: 10428421
references.citation: N Engl J Med. 1986 Apr 10;314(15):953-8
references.pmid: 3960059
references.citation: Brain Res. 2001 Mar 2;893(1-2):104-12
references.pmid: 11222998
references.citation: Stroke. 2007 May;38(5):1585-9
references.pmid: 17363720
references.citation: Neurology. 2009 Dec 8;73(23):1963-8
references.pmid: 19996072
references.citation: Redox Rep. 2009;14(6):228-35
references.pmid: 20003707
references.citation: Neurocrit Care. 2006;4(2):168-78
references.pmid: 16627909